QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=6F2156FD0A5778107C1127A0843C523D;jsessionid=357B8AC73D71B27953C3F0AFF999FCDF;jsessionid=19C02E302B0B6F9E4CF1DD3AF9BFD9BF;jsessionid=0B3CA7C069E8AC865905BA03CC2F78AD;jsessionid=7D81DE62A033C08A615057C334C6A59C;jsessionid=AB7D226C96E8BC3A800A6A36216A0EBE;jsessionid=CC29A1A71A6B191ECEE50FB4D31860A0;jsessionid=3A47C0FAA5FD26374A366E5C82221483;jsessionid=D2196239374D1BFF4DA807A12DA41992;jsessionid=D767023A1D0EA690E78EC8CC26F40092;jsessionid=A3787547F6CFDCB1A267C7F9CC4C55FD;jsessionid=7AED24A9A7B19EEF140040FD54C13770;jsessionid=C0787AF6038F2A63D6FE92B415EFBA8A;jsessionid=5C26F3A437DB57C2D6E7BD291CFF7AC9;jsessionid=339627894AC908277BBCC9A3A51F8A07;jsessionid=809AE08565DD5803CB13FA9CA5BFA445 (gene)

There were no matches for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=6F2156FD0A5778107C1127A0843C523D;jsessionid=357B8AC73D71B27953C3F0AFF999FCDF;jsessionid=19C02E302B0B6F9E4CF1DD3AF9BFD9BF;jsessionid=0B3CA7C069E8AC865905BA03CC2F78AD;jsessionid=7D81DE62A033C08A615057C334C6A59C;jsessionid=AB7D226C96E8BC3A800A6A36216A0EBE;jsessionid=CC29A1A71A6B191ECEE50FB4D31860A0;jsessionid=3A47C0FAA5FD26374A366E5C82221483;jsessionid=D2196239374D1BFF4DA807A12DA41992;jsessionid=D767023A1D0EA690E78EC8CC26F40092;jsessionid=A3787547F6CFDCB1A267C7F9CC4C55FD;jsessionid=7AED24A9A7B19EEF140040FD54C13770;jsessionid=C0787AF6038F2A63D6FE92B415EFBA8A;jsessionid=5C26F3A437DB57C2D6E7BD291CFF7AC9;jsessionid=339627894AC908277BBCC9A3A51F8A07;jsessionid=809AE08565DD5803CB13FA9CA5BFA445

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=6F2156FD0A5778107C1127A0843C523D;jsessionid=357B8AC73D71B27953C3F0AFF999FCDF;jsessionid=19C02E302B0B6F9E4CF1DD3AF9BFD9BF;jsessionid=0B3CA7C069E8AC865905BA03CC2F78AD;jsessionid=7D81DE62A033C08A615057C334C6A59C;jsessionid=AB7D226C96E8BC3A800A6A36216A0EBE;jsessionid=CC29A1A71A6B191ECEE50FB4D31860A0;jsessionid=3A47C0FAA5FD26374A366E5C82221483;jsessionid=D2196239374D1BFF4DA807A12DA41992;jsessionid=D767023A1D0EA690E78EC8CC26F40092;jsessionid=A3787547F6CFDCB1A267C7F9CC4C55FD;jsessionid=7AED24A9A7B19EEF140040FD54C13770;jsessionid=C0787AF6038F2A63D6FE92B415EFBA8A;jsessionid=5C26F3A437DB57C2D6E7BD291CFF7AC9;jsessionid=339627894AC908277BBCC9A3A51F8A07;jsessionid=809AE08565DD5803CB13FA9CA5BFA445